FIRST CITIZENS BANK & TRUST CO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST CITIZENS BANK & TRUST CO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$213,000
-16.1%
4,233
-0.4%
0.02%
-22.6%
Q2 2018$254,000
+12.9%
4,251
-13.3%
0.03%0.0%
Q1 2018$225,000
-3.4%
4,903
-9.2%
0.03%
+3.3%
Q2 2017$233,000
+12.0%
5,397
-18.6%
0.03%
+20.0%
Q1 2017$208,000
-13.7%
6,631
-32.0%
0.02%
+13.6%
Q3 2016$241,0009,7450.02%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders